K Number
K043194
Device Name
VOXAR 3D PRODUCT FAMILY
Manufacturer
Date Cleared
2005-01-11

(54 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Voxar 3D product family is a suite of products that is intended to provide Physicians, Clinicians and Radiologists with tools to aid them in reading and interpreting DICOM compliant tomographic medical imaging. The Voxar 3D product family provides several levels of functionality to the user .- - Basic analysis tools they use on a daily basis, such as 2D review, orthogonal . multi planar reconstructions (mpr's), oblique mpr's, curved / cross - curved MPR's, slab MPR's AveiP, MIP, MinIP, measurements, annotations, reporting, distribution, etc. - Tools for in depth analysis, such as segmentation, enescopic review, colour VR . slab, 3D volume review, path definition and boundary detection, PET imagery analysis, etc - Specialist tools and workflow enhancements for specific clinical applications . which provide targeted workflows, custom UI, targeted measurement and reporting functions including colon Screening (which is intended for the screening of patients for colonic polyps, tumours and other lesions using tomographic Colonography), calcium scoring (which is intended for non - invasive identification and quantification of calcifieatherosclerotic plaques in the coronary arteries using tomographic medical image data and clinically accepted calcium scoring algorithms), Vessel analysis (which is intended for the qualative and quantative analysis of tomographic angiographic studies to evaluate occlusive and aneurysmal disease), etc
Device Description
Not Found
More Information

Not Found

Not Found

No
The document describes standard image processing and analysis tools commonly found in medical imaging software, without mentioning AI or ML.

No
The device provides tools for reading and interpreting medical images, aiding in diagnosis rather than directly treating or preventing a disease.

Yes
The device is intended to provide tools for Physicians, Clinicians, and Radiologists to aid in reading and interpreting medical imaging for various analyses, including screening for colonic polyps, tumors, and other lesions, and quantifying calcified atherosclerotic plaques. These activities are directly involved in diagnosing medical conditions.

Unknown

The provided text describes the functionality of the "Voxar 3D product family" as a suite of tools for reading and interpreting medical imaging. While it details various software-based analysis and visualization features, it lacks a "Device Description" section which would explicitly state whether the device is purely software or includes associated hardware components. Without this information, it's impossible to definitively determine if it's a software-only medical device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states that the device is intended to provide tools to aid physicians, clinicians, and radiologists in reading and interpreting medical imaging. This is a core function of medical image analysis software, which falls under the category of medical devices, but not specifically IVDs.
  • IVD Definition: In Vitro Diagnostics are devices used to examine specimens derived from the human body (like blood, urine, tissue) to provide information about a person's health. This device does not interact with or analyze such specimens. It analyzes medical images.
  • Lack of IVD-Specific Information: The provided information lacks any mention of analyzing biological samples, performing tests on bodily fluids or tissues, or providing diagnostic information based on such analyses.

The device is clearly a medical image analysis software intended for use by healthcare professionals to interpret medical images. While it aids in diagnosis, it does so by processing and presenting image data, not by analyzing biological samples.

N/A

Intended Use / Indications for Use

The Voxar 3D product family is a suite of products that is intended to provide Physicians, Clinicians and Radiologists with tools to aid them in reading and interpreting DICOM compliant tomographic medical imaging.

The Voxar 3D product family provides several levels of functionality to the user .-

  • Basic analysis tools they use on a daily basis, such as 2D review, orthogonal . multi planar reconstructions (mpr's), oblique mpr's, curved / cross - curved MPR's, slab MPR's AveiP, MIP, MinIP, measurements, annotations, reporting, distribution, etc.
  • Tools for in depth analysis, such as segmentation, enescopic review, colour VR . slab, 3D volume review, path definition and boundary detection, PET imagery analysis, etc
  • Specialist tools and workflow enhancements for specific clinical applications . which provide targeted workflows, custom UI, targeted measurement and reporting functions including colon Screening (which is intended for the screening of patients for colonic polyps, tumours and other lesions using tomographic Colonography), calcium scoring (which is intended for non - invasive identification and quantification of calcifieatherosclerotic plaques in the coronary arteries using tomographic medical image data and clinically accepted calcium scoring algorithms), Vessel analysis (which is intended for the qualative and quantative analysis of tomographic angiographic studies to evaluate occlusive and aneurysmal disease), etc

Product codes (comma separated list FDA assigned to the subject device)

90 LLZ

Device Description

Not Found

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

DICOM compliant tomographic medical imaging

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Physicians, Clinicians and Radiologists

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Not Found

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or bird in flight, composed of three curved lines.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JAN 1 1 2005

Voxar Ltd. % Mr. Jeff Rongero Senior Project Engineer Underwriters Laboratories, Inc. 12 Laboratory Drive P.O. Box 13995 Research Triangle Park, NC 27709 Re: K043194 Trade/Device Name: Voxar 3D Product Family Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: 90 LLZ Dated: December 17, 2004 Received: December 27, 2004

Dear Mr. Rongero:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced n ove and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been redy 20, 11 is accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include registements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

1

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally premated predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

21 CFR 876.xxxx(Gastroenterology/Renal/Urology)240-276-0115
21 CFR 884.xxxx(Obstetrics/Gynecology)240-276-0115
21 CFR 892.xxxx(Radiology)240-276-0120
Other240-276-0100

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

Applicant:

Voxar Ltd, Bonnington Bond, 2 Anderson Place, Edinburgh, EH6 5NP, UK

510(k) Number (if known):

Unknown RU4 3194

Device Name:

Voxar 3D Product Family

Indications For Use:

The Voxar 3D product family is a suite of products that is intended to provide Physicians, Clinicians and Radiologists with tools to aid them in reading and interpreting DICOM compliant tomographic medical imaging.

The Voxar 3D product family provides several levels of functionality to the user .-

  • Basic analysis tools they use on a daily basis, such as 2D review, orthogonal . multi planar reconstructions (mpr's), oblique mpr's, curved / cross - curved MPR's, slab MPR's AveiP, MIP, MinIP, measurements, annotations, reporting, distribution, etc.
  • Tools for in depth analysis, such as segmentation, enescopic review, colour VR . slab, 3D volume review, path definition and boundary detection, PET imagery analysis, etc
  • Specialist tools and workflow enhancements for specific clinical applications . which provide targeted workflows, custom UI, targeted measurement and reporting functions including colon Screening (which is intended for the screening of patients for colonic polyps, tumours and other lesions using tomographic Colonography), calcium scoring (which is intended for non - invasive identification and quantification of calcifieatherosclerotic plaques in the coronary arteries using tomographic medical image data and clinically accepted calcium scoring algorithms), Vessel analysis (which is intended for the qualative and quantative analysis of tomographic angiographic studies to evaluate occlusive and aneurysmal disease), etc

× Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

David A. Lynn

Page 1 of 1

(Division Sign-Off)
Division of Reproductive. Abdominal,
and Radiological Devices
510(k) Submission Page C1
510(k) Number K043194